ARCHIVES

Oblimersen Combination Improves CLL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986

NCI Approved Clinical Trials

May 28, 2010

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014